Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Ribavirin 200mg Capsule
  Indications :
 

Chronic Hepatitis B

In patients previously untreated with alpha interferon

In patients who have relapsed following alpha interferon therapy

   
  Dosage :
 

Ribavirin must be used in combination with either peginterferon alfa-2b or interferon alfa-2b.

The dose of Ribavirin is based on patient body weight.

Ribavirin capsules are to be administered orally each day in two divided doses (morning and evening) with food.

Adults : The dose of Ribavirin is based on patient body weight.
Ribavirin must be used in combination with either peginterferon alfa-2b (1.5 micrograms/kg/week) or interferon alfa-2b (3 million international units [MIU] three times a week). The choice of combination regimen is based on the characteristics of the patient.

ribapro_table

Children 3 years of age & older and adolescents : Dosing for children and adolescent patients is determined by body weight for Ribavirin and by body surface area for peginterferon alfa-2b and interferon alfa-2b.

Renally Impaired Patients : Dosage adjustment required.

   
  Packing : 5 Strips 8 Tablets
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.